Login / Signup
Victor Hagenau
ORCID
Publication Activity (10 Years)
Years Active: 2024-2024
Publications (10 Years): 4
Top Topics
Chronic Obstructive Pulmonary Disease
Clinical Trial
Open Label
Mesenchymal Stem Cells
Top Venues
Trials
</>
This page only lists publications with an associated author ORCID identifier.
Publications
</>
Arne Sylvester Rønde Jensen
,
Jan Brink Valentin
,
Mathilde Gundgaard Mulvad
,
Victor Hagenau
,
Søren Helbo Skaarup
,
Soeren Paaske Johnsen
,
Ulla Vaeggemose
,
Martin Faurholdt Gude
Standard vs. targeted oxygen therapy prehospitally for chronic obstructive pulmonary disease (STOP-COPD): study protocol for a randomised controlled trial.
Trials
25 (1) (2024)
Arne Sylvester Rønde Jensen
,
Jan Brink Valentin
,
Mathilde Gundgaard Mulvad
,
Victor Hagenau
,
Søren Helbo Skaarup
,
Soeren Paaske Johnsen
,
Ulla Vaeggemose
,
Martin Faurholdt Gude
Standard vs. targeted oxygen therapy prehospitally for chronic obstructive pulmonary disease (STOP-COPD): study protocol for a randomised controlled trial.
Trials
25 (1) (2024)
Arne Sylvester Rønde Jensen
,
Jan Brink Valentin
,
Mathilde Gundgaard Mulvad
,
Victor Hagenau
,
Søren Helbo Skaarup
,
Soeren Paaske Johnsen
,
Ulla Vaeggemose
,
Martin Faurholdt Gude
Standard vs. targeted oxygen therapy prehospitally for chronic obstructive pulmonary disease (STOP-COPD): study protocol for a randomised controlled trial.
Trials
25 (1) (2024)
Arne Sylvester Rønde Jensen
,
Jan Brink Valentin
,
Mathilde Gundgaard Mulvad
,
Victor Hagenau
,
Søren Helbo Skaarup
,
Soeren Paaske Johnsen
,
Ulla Vaeggemose
,
Martin Faurholdt Gude
Standard vs. targeted oxygen therapy prehospitally for chronic obstructive pulmonary disease (STOP-COPD): study protocol for a randomised controlled trial.
Trials
25 (1) (2024)